Using proprietary genomic insights developed by world-renowned geneticist, Dr. Mansoor Mohammed, My Next Health (MNH) seeks to transform healthcare by significantly improving health outcomes and reducing costs through clinical trials and digital therapeutics. These insights for a variety of health conditions were gained through 10,000+ case studies conducted over 5 years. Dr. Mohammed’s earlier research collaborations contributed to the discovery of the genomic phenomena of Copy Number Variation as well as genomic insights into breast cancer. These were published in prominent journals and short-listed for a Nobel Prize in Medicine/Physiology.
MY NEXT HEALTH
- Genomic insights expected to disrupt standard healthcare with precision medicine.
- New paradigm and therapeutics for clinical trials.
- Immediate expected opportunities related to COVID-19 pandemic.
- Significant expected costs savings for insurance companies from novel risk-assessment platform.
- Experienced management team.
- Strong affiliates and strategic partnerships.
PLATFORM FOR INFECTIOUS DISEASES
- AI & genomics-powered digital healthcare app for self-management of health.
- Proprietary analytics used to uncover an individual’s genotype through an application developed with IBM Watson to improve outcomes for COVID-19.
- Initial case studies demonstrate breakthrough improvements and dramatic cost savings over current best practices through precision therapeutic recommendations.
- Can be used for other coronaviruses and other infectious diseases (e.g. influenza).
The public version will be available at www.mynexthealth.com.
Innovation is Next
Using proprietary genomic insights developed by world-renowned geneticist, Dr. Mansoor Mohammed, My Next Health (MNH) seeks to transform healthcare by significantly improving health outcomes and reducing costs through clinical trials and digital therapeutics. These insights for a variety of health conditions were gained through 10,000+ case studies conducted over 5 years. Dr. Mohammed’s earlier research collaborations contributed to the discovery of the genomic phenomena of Copy Number Variation as well as genomic insights into breast cancer. These were published in prominent journals and short-listed for a Nobel Prize in Medicine/Physiology.
MY NEXT HEALTH
- Genomic insights expected to disrupt standard healthcare with precision medicine.
- New paradigm and therapeutics for clinical trials.
- Immediate expected opportunities related to COVID-19 pandemic.
- Significant expected costs savings for insurance companies from novel risk-assessment platform.
- Experienced management team.
- Strong affiliates and strategic partnerships.
PLATFORM FOR INFECTIOUS DISEASES
- AI & genomics-powered digital healthcare app for self-management of health.
- Proprietary analytics used to uncover an individual’s genotype through an application developed with IBM Watson to improve outcomes for COVID-19.
- Initial case studies demonstrate breakthrough improvements and dramatic cost savings over current best practices through precision therapeutic recommendations.
- Can be used for other coronaviruses and other infectious diseases (e.g. influenza).
The public version will be available at www.mynexthealth.com.